Nutrien (NTR) Q1 2026 Earnings Transcript

Nutrien reported Q1 adjusted EBITDA of $1.1 billion, led by record potash sales of more than 3.5 million tonnes and potash EBITDA of $578 million, while nitrogen EBITDA was $482 million and retail EBITDA was $108 million. Management kept full-year guidance unchanged for potash, nitrogen, retail EBITDA ($1.75 billion-$1.95 billion), capital spending ($2.0 billion-$2.1 billion), and share buybacks at about $55 million per month. The main offset is pressure on phosphate margins from higher sulfur and ammonia costs, alongside ongoing portfolio reviews and geopolitical disruption that is supporting fertilizer prices but raising logistics and input costs.

Analysis

NTR’s real signal is not the beat; it is that the company is converting a geopolitical supply shock into pricing power while preserving operating discipline. The second-order winner is the integrated North American asset base: low-cost potash and nitrogen can reprice into a tighter global system while the company’s retail network acts as a natural hedge, capturing margin on the way down the chain. That combination should widen the valuation gap versus higher-cost global fertilizer producers that rely on Middle East-linked feedstock or fragile logistics.

The more important takeaway is that the market is still underestimating duration. Even if the Strait reopens quickly, restart friction, damaged infrastructure, insurance premia, and customer restocking behavior argue for a multi-quarter rather than multi-week tightening cycle. That supports a favorable setup for potash first, nitrogen second, and phosphate as a relative loser because input inflation is outrunning finished-price pass-through; the phosphate review looks less like optionality and more like forced recapitalization of a structurally broken asset.

The main contrarian risk is that consensus treats this as a clean earnings upgrade while ignoring cyclicality in farmer behavior and channel inventory normalization. If growers push purchases into the back half or inventory refills lag, pricing can remain firm but volumes may soften just as the company has less room to surprise on capital returns. The stock likely needs either another leg higher in nitrogen/urea or a tangible portfolio action announcement to sustain rerating; absent that, the move is probably better expressed as a relative trade than an outright long.

Key Decisions for Investors

• Long NTR vs. short CF for the next 1-2 quarters: NTR has cleaner exposure to tight potash and better capital allocation, while CF carries more direct nitrogen price volatility and less diversified downside support.
• Buy NTR on any 3-5% pullback, targeting a 10-15% move over 3-6 months if nitrogen and potash pricing remain elevated into summer refill season.
• Pair trade: long NTR / short MOS as a relative-quality trade; NTR’s upstream + retail mix should outperform if fertilizer prices stay firm but volumes normalize unevenly.
• Avoid chasing phosphate-exposed names for now; use any strength in the fertilizer space to rotate out of pure phosphate leverage until there is clarity on asset sales or sulfur normalization.
• For options traders, buy 3-6 month NTR calls financed by selling out-of-the-money puts only if willing to own the stock; the skew should remain favorable as geopolitical headlines keep implied vol elevated.